Shiraishi, Takuya
Nishizawa, Yuji
Yamamoto, Hiroyuki
Tsukada, Yuichiro
Sasaki, Takeshi
Ito, Masaaki
Article History
Received: 27 July 2018
Accepted: 2 September 2018
First Online: 15 September 2018
Compliance with ethical standards
:
: Dr. Ito is on the speakers’ bureaus of Johnson & Johnson K.K., Eisai Co., Ltd., Olympus Corporation, Medtronic plc, Chugai Pharmaceutical Co., Ltd., KAKEN PHARMACE, UTICAL CO., LTD., Stryker Japan K.K., Covidien Japan, TAIHO PHARMACEUTICAL CO., LTD., Yakult Honsha Co., Ltd., Fujita Medical Instruments Co., Ltd., Japan Medical Engineering Institute, MSD K.K., Merck Serono Co., Ltd., Medical Leaders Co., Ltd., Takeda Pharmaceutical Company Limited, Applied Medical, MC Medical, Inc., EA Pharma Co., Ltd., and ConMed Japan KK. He received Grants of ConMed Japan KK, Mitsubishi Precision, MURANAKA MEDICAL INSTRUMENTS, FUJITA MEDICAL INSTRUMENTS, and A1 Technica. He has an equity interest in A-Trantion. Drs. Shiraishi, Nishizawa, Yamamoto, Tsukada, and Sasaki have no conflicts of interest or financial ties to disclose.
: The study was approved by the institutional review board.
: For this type of study formal consent is not required.